社会焦虑障碍

最后审阅: 2 六月 2022
最后更新: 05 十月 2021

小结

定义

病史和体格检查

关键诊断因素

  • 存在的危险因素
  • 预期焦虑及担忧
  • 心动过速
  • 过度换气
  • 出汗
  • 潮红
  • 肌肉紧张
更多 关键诊断因素

其他诊断因素

  • 事后回放
  • 注意偏差
  • 社交技能缺陷
  • 哭泣、发怒或“凝固
  • 选择性缄默症
其他诊断因素

危险因素

  • 精神性合并症(如焦虑障碍、心境障碍以及物质使用障碍)
  • 遗传学
  • 气质因素
  • 教养方式
  • 心理障碍
  • 生活应激
  • 环境因素
更多 危险因素

诊断性检查

首要检查

  • 临床诊断
更多 首要检查

需考虑的检查

  • 血糖
  • 血清促甲状腺激素
  • 毒理学筛查(尿液和血液)
更多 需考虑的检查

治疗流程

持续性治疗

成人:无合并症

成人:合并症

儿童和青少年

撰稿人

作者

Craig N. Sawchuk, PhD
Craig N. Sawchuk

Professor

Department of Psychiatry and Psychology

Mayo Clinic

Rochester

MN

利益声明

CNS declares that he has no competing interests.

Jason P. Veitengruber, MD
Jason P. Veitengruber

Associate Professor

Department of Psychiatry and Behavioral Sciences

University of Washington School of Medicine

Seattle

WA

利益声明

JPV is an author of a reference cited in this topic.

Bunmi O. Olatunji, PhD
Bunmi O. Olatunji

Professor

Department of Psychological Sciences

Vanderbilt University

Nashville

TN

利益声明

BOO declares that he has no competing interests.

Stacy Shaw Welch, PhD
Stacy Shaw Welch

Director

Anxiety and Stress Reduction Center of Seattle

University of Washington

Seattle

WA

利益声明

SSW declares that she has no competing interests.

同行评议者

Richard P. Swinson, MD, FRCPC, FRCPsych

Emeritus Professor

Medical Director

Anxiety Treatment and Research Centre

McMaster University and St Joseph’s Hospital

Hamilton

Canada

利益声明

RPS declares that he has no competing interests.

Jeffrey M. Lohr, PhD

Professor

Department of Psychology

University of Arkansas

Fayetteville

AR

利益声明

JML declares that he has no competing interests.

David F. Tolin, PhD

Professor

Institute of Living

Yale University

New Haven

CT

利益声明

DFT declares that he has no competing interests.

David Baldwin, MD

Professor of Psychiatry

University of Southampton

Southampton

UK

利益声明

DB has acted as a consultant for and held research grants from Cephalon, Eli Lilly, GSK, Lundbeck, Organon, Pfizer, Pharmacia, Roche, and Wyeth and has also acted as a consultant to Asahi, AstraZeneca, Grunenthal, Pierre Fabre, Servier, Sumitomo, and Wyeth. He has accepted paid speaking engagements in industry-supported satellite symposia and is co-author of the BAP evidence-based guidelines on the treatment of anxiety disorders. He is also a Medical Patron of Anxiety UK.

  • 鉴别诊断

    • 恐怖症
    • 惊恐障碍
    • 广场恐怖症
    更多 鉴别诊断
  • 指南

    • 儿童和青少年焦虑障碍评估及治疗临床实践指南
    • 有关治疗惊恐障碍、社交性焦虑障碍和广泛性焦虑障碍的临床实践指南
    更多 指南
  • 患者教育信息

    何为焦虑?

    焦虑:如何有效治疗?

    更多 患者教育信息
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明